Home

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Signaling Pathways

Chemical Structure Cat. No. Product Name CAS No.
Pirlimycin hydrochloride Chemical Structure
BCP31935 Pirlimycin hydrochloride 78822-40-9
Pirlimycin Hydrochloride is a semi-synthetic lincosaminide antibiotic. Pirlimycin Hydrochloride is a Clindamycin analog.
Pirlimycin Chemical Structure
BCP31934 Pirlimycin 79548-73-5
Pirlimycin is a semi-synthetic lincosamide prepared from clindamycin by hydrolysing the propyl N-methylproline and re-annealing a 4-ethylpipecolic acid; a broad spectrum antibiotic with activity against anaerobic bacteria and protozoans by binding to the 23S ribosomal subunit, blocking protein synthesis
BI-4020 Chemical Structure
BCP31931 BI-4020 BI4020
BI-4020 is a fourth-generation, orally active, and non-covalent EGFR tyrosine kinase inhibitor. BI-4020 inhibits not only the triple mutant EGFR del19 T790M C797S variant (IC50=0.2 nM in BaF3 cell lines) but also the double mutant EGFR del19 T790M and primary mutant EGFR del19 (IC50=1 nM). BI-4020 also shows activity against EGFR wt (IC50=190 nM). BI-4020 shows high kinome selectivity and good DMPK properties.
DBCO-NHS Chemical Structure
BCP31927 DBCO-NHS 1353016-71-3
DBCO-NHS is an amine-reactive compound and can be used to modify an amine-containing molecule in organic solvents (limited solubility in aqueous media).
GB1107 Chemical Structure
BCP31924 GB1107 1978336-61-6
GB1107 is a potent, selective, orally active galectin-3 inhibitor with Kd of 37 nM. GB1107 Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade.
AB-680 Chemical Structure
BCP31923 AB-680 2105904-82-1
AB-680 is highly potent, reversible and selective small molecule inhibitor of CD73 (an ecto-nucleotidase), with a Ki of 4.9 pM for hCD73, displays >10,000-fold selectivity over related ecto-nucleotidases CD39. Anti-tumor activity.
BRD0539 Chemical Structure
BCP31922 BRD0539 1403838-79-8
BRD0539 is a SpCas9 inhibitor.
Sitafloxacin hydrate (2:3) Chemical Structure
BCP31925 Sitafloxacin hydrate (2:3) 163253-35-8
Sitafloxacin Hydrate is a new-generation, broad-spectrum oral fluoroquinolone antibiotic.
JBJ-04-125-02 Chemical Structure
BCP31914 JBJ-04-125-02 2140807-05-0
JBJ-04-125-02 is a single agent can inhibit cell proliferation and EGFRL858R/T790M/C797S signaling in vitro and in vivo.
Valemetostat Chemical Structure
BCP31915 Valemetostat 1809336-39-7
Valemetostat, also known as DS-3201, is an antineoplastic drug candidate.
123下一页末页共 7484 条记录 1 / 749 页 
0086-15971444841